My Market Wizard

Tonix Pharmaceuticals Holding Corp. 8-K Analysis & Summary – 2/21/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

Tonix Pharmaceuticals Holding C

Filing date:

02/21/2025

TLDR:

Tonix Pharmaceuticals regained compliance with NASDAQ’s minimum bid price requirement and will continue to be listed on the NASDAQ Capital Market.

ELI5:

Tonix Pharmaceuticals’ stock price is back above $1, so they meet NASDAQ’s rules to stay listed on the stock market.

Accession #:

0001999371-25-001802

Published on

Analyst Summary

  • Tonix Pharmaceuticals regained compliance with NASDAQ Listing Rule 5550(a)(2).
  • The Company’s shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days.

Potential Implications

Stock Price

  • Continued listing on the NASDAQ Capital Market.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️